US Database Study of Clinical Burden and Unmet Need in Recurrent Pericarditis
Background Patients with recurrent pericarditis (RP) may develop complications, multiple recurrences, or inadequate treatment response. This study aimed to characterize disease burden and unmet needs in RP.
Allan Klein +7 more
doaj +3 more sources
IL-1 Pathway Inhibition in Recurrent Pericarditis Management: Real-World Adoption of Corticosteroid Sparing in RESONANCE. [PDF]
Background Recurrent pericarditis (RP) guidelines recommend second-line corticosteroids after aspirin/nonsteroidal anti-inflammatory drugs/colchicine, but complications of protracted use underscore the importance of corticosteroid-sparing strategies ...
Cremer PC +11 more
europepmc +2 more sources
Incidence and Factors Associated With Recurrent Pericarditis in Lupus.
This cohort study investigates the incidence of recurrent pericarditis among patients with a history of systemic lupus erythematosus (SLE) and factors associated with recurrence.
Kim YJ +7 more
europepmc +2 more sources
Recurrent pericarditis in a patient with Bardet–Biedl syndrome: A case report [PDF]
Bardet–Biedl syndrome is a rare autosomal recessive disorder characterized by rod-cone dystrophy, renal dysfunction, obesity, learning difficulties, hypogonadism, polydactyl, and many other minor features that can affect the cardiovascular, locomotive ...
Angela Mauro +8 more
doaj +2 more sources
Running into trouble: exercise-exacerbated recurrent pericarditis-a case report. [PDF]
Background Recurrent pericarditis is an inflammatory condition characterized by symptom recurrence after an initial episode. Exercise-induced flares are underrecognized.
Calcagno T +3 more
europepmc +2 more sources
Rilonacept in Refractory Immune Checkpoint Inhibitor-Induced Recurrent Pericarditis: A Potential Treatment Option. [PDF]
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment but are associated with rare immune-related adverse events, particularly cardiotoxicity.
Patel H, Thangjui S, Watson H, Balla S.
europepmc +2 more sources
Duration of Disease and Long-Term Outcomes in Patients With Difficult-To-Treat Recurrent Pericarditis: A Chronic Condition Treated With Nonsteroidal Anti-Inflammatory Drugs, Colchicine, Corticosteroids, and Anti-Interleukin-1 Agents. [PDF]
We aimed to investigate the remission rate and disease duration in idiopathic or post–cardiac injury pericarditis and risk factors for disease duration and anti–interleukin‐1 (IL‐1) agent discontinuation.
Ceriani E +18 more
europepmc +2 more sources
Recurrent Pericarditis and Paradigm Shift in Cardiovascular Imaging and Targeted Therapeutics. [PDF]
Recurrent pericarditis poses a significant challenge to patients and clinicians given its high morbidity and health care burden. Since the last iteration of European Society of Cardiology Guidelines in 2015, further insights have been gained into the ...
Karmali R +7 more
europepmc +2 more sources
Genetic variants in patients with recurrent pericarditis. [PDF]
Aims Presence of family cases and multiple recurrences of pericarditis suggest the existence of a possible genetic background in at least 10% of cases.
Imazio M +8 more
europepmc +2 more sources
Emerging Therapies for Recurrent Pericarditis: Interleukin‐1 inhibitors
Recurrent pericarditis (RP) is a complex inflammatory disorder associated with adverse outcomes and poor quality of life. After the first episode of acute pericarditis, a non‐negligible group of patients will fail to achieve complete remission despite ...
Saberio Lo Presti +5 more
doaj +3 more sources

